Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Leukemia 54Myelodysplastic Syndromes 41Lymphoma, Non-Hodgkin 15Congenital Abnormalities 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma 12Recurrence 11Leukemia, Myelomonocytic, Chronic 11Hodgkin Disease 11Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Megakaryoblastic, Acute 10Leukemia, Erythroblastic, Acute 10Leukemia, Biphenotypic, Acute 9Hematologic Neoplasms 9Neoplasms 7Anemia, Refractory, with Excess of Blasts 7Multiple Myeloma 6Leukemia, Myelomonocytic, Juvenile 6Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Graft vs Host Disease 5Burkitt Lymphoma 5Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4

Interventions

Cyclophosphamide 19fludarabine phosphate 18Whole-Body Irradiation 16Melphalan 15fludarabine 13Tacrolimus 13Busulfan 13Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Antilymphocyte Serum 6Alemtuzumab 6Methotrexate 5Cyclosporine 5Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3Transplantation 2Sirolimus 2Rituximab 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2Cord Blood Stem Cell Transplantation 2visilizumab 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × Clofarabine × Other hematologic neoplasm × Clear all
NCT01500161 2013-11-25

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Texas Oncology Cancer Center

Phase 2 Terminated
1 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡